STOCK TITAN
  1. Home
  2. DNQWF

Denali Capital Acq CP WTS (DNQWF) Stock Price, News & Analysis

DNQWF OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
40 70 sessions, April 16, 2025 to September 22, 2025
Largest daily move
+792.9% close of April 17, 2025
1-month change
-20.5% closing prices, August 22, 2025 to September 22, 2025

Company Description

DNQWF declined 20.5% in the month to September 22, 2025. The last closing price was $0.1350.

For FY2025, Denali Capital Acq CP WTS reported diluted earnings per share of -$0.78.

This page collects what Stock Titan holds for DNQWF, including price data, SEC filings, and financial highlights.

Stock Performance

Chart
$0.1350
No recent trading
Last close: September 22, 2025
-20.5%
1 month to September 22, 2025
-
Market Cap
-
Shares outstanding

Denali Capital Acq CP WTS (DNQWF) closed at $0.1350 on September 22, 2025. In the month to September 22, 2025, the price lost 20.5%.

See what a $1,000 investment in DNQWF would be worth today

Average down calculator for DNQWF

DNQWF Metrics & Rankings

September 2025
-30.4%
—

Price returns through September 22, 2025. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All

No recent news available for DNQWF.

SEC Filings

View All

[10-Q] Semnur Pharmaceuticals (SMNR) Q1 2026 loss, cancelled financings and cash crunch

[DEF 14A] Semnur Pharmaceuticals, Inc. Definitive Proxy Statement

[8-K] Semnur Pharmaceuticals (SMNR) cancels PIPE deals for 7.5M shares at $16

[8-K] Leadership shifts at Semnur Pharmaceuticals (OTCQB: SMNR) as Henry Ji becomes CEO

[10-K] SP-102 sciatica program and growth plans at Semnur Pharmaceuticals (SMNR)

[S-1/A] Semnur Pharmaceuticals (SMNR) files amended S-1 for 203.7M share resale and warrants

[8-K] Semnur Pharmaceuticals (SMNR) refreshes securities description after charter changes

[10-Q] Semnur Pharmaceuticals, Inc. Quarterly Earnings Report

[S-1] Semnur registers warrant share issuance and large resale post-merger

[3] Initial Form 3: Large Semnur/Denali Option Filed; Exercisability Linked to Debt Repayment

Denali Capital Acq CP WTS has filed 10 recent SEC filings, including 3 Form 8-K, 2 Form 10-Q, 1 Form 3, 1 Form DEF 14A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DNQWF SEC filings →

Financial Highlights

View Full Financials

Denali Capital Acq CP WTS reported diluted earnings per share of -$0.78 in FY2025. The company generated -$5.9M in operating cash flow. The current ratio was 0.06, measuring current assets divided by current liabilities.

-$0.78
Diluted EPS (FY2025)
-$5.9M
Operating Cash Flow
0.06
Current Ratio
—
Revenue (FY2025)
—
Net Income (FY2025)
—
Net Profit Margin

Upcoming Events

No upcoming events scheduled for DNQWF.

Frequently Asked Questions

Denali Capital Acq CP WTS (DNQWF) has no recent trading. Its last close was $0.1350 on September 22, 2025.

The diluted earnings per share (EPS) of Denali Capital Acq CP WTS (DNQWF) is -$0.78 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Denali Capital Acq CP WTS (DNQWF) is -$5.9M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The current ratio of Denali Capital Acq CP WTS (DNQWF), current assets divided by current liabilities, was 0.06 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.